Your browser doesn't support javascript.
loading
SARS-CoV-2 B.1.1.7 Decline Is Not Driven by the Introduction of a More Successful Variant.
Rodríguez-Grande, Cristina; Buenestado-Serrano, Sergio; Alcalá, Luis; Sola-Campoy, Pedro J; Molero-Salinas, Andrea; Otero-Sobrino, Álvaro; Rodríguez-Grande, Jorge; de la Cueva García, Víctor Manuel; Adán-Jiménez, Javier; Rico-Luna, Carla; Losada, Carmen; Catalán, Pilar; Muñoz, Patricia; Pérez-Lago, Laura; García de Viedma, Darío.
Affiliation
  • Rodríguez-Grande C; Servicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
  • Buenestado-Serrano S; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
  • Alcalá L; Servicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
  • Sola-Campoy PJ; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
  • Molero-Salinas A; Servicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
  • Otero-Sobrino Á; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
  • Rodríguez-Grande J; CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain.
  • de la Cueva García VM; Servicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
  • Adán-Jiménez J; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
  • Rico-Luna C; Servicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
  • Losada C; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
  • Catalán P; Servicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
  • Muñoz P; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
  • Pérez-Lago L; Servicio de Microbiología Clínica y Enfermedades Infecciosas, Gregorio Marañón General University Hospital, Madrid, Spain.
  • García de Viedma D; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Microbiol Spectr ; 9(3): e0112821, 2021 12 22.
Article in En | MEDLINE | ID: mdl-34787494
The SARS-CoV-2 variant of concern (VOC) Delta (B.617.2 lineage) displaced the predominant VOC Alpha (B.1.1.7 lineage) in the United Kingdom. In Madrid, recent start of the decline of predominant VOC Alpha suggested an equivalent phenomenon. However, 11 different variants, none overrepresented in frequency, occupied progressively over a period of 7 weeks the niche previously dominated by VOC Alpha. Only after these 7 weeks, VOC Delta started to emerge. Viral competition due to the entry of VOC Delta is not the major force driving the start of VOC Alpha decline in Madrid. IMPORTANCE Our data indicate that the dynamics of SARS-CoV-2 VOCs turnover in our setting differ from those proposed for other countries. A systematic genomic analysis, updated on a weekly basis, of representative randomly selected samples of SARS-CoV-2 circulating variants allowed us to define a lapse of 7 weeks between the start of VOC Alpha decline and the final emergence of VOC Delta. During this period, VOC Alpha showed a sustained decline, while 11 VOCs, variants of interest (VOIs), and other identified variants, none overrepresented, occupied the niche left by VOC Alpha. Only after these 7 weeks, emergence of VOC Delta occurred, indicating that viral competition involving VOC Delta was not the exclusive direct driving force behind the starting of VOC Alpha decline.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phylogeny / SARS-CoV-2 / COVID-19 Limits: Humans Country/Region as subject: Europa Language: En Journal: Microbiol Spectr Year: 2021 Document type: Article Affiliation country: España Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phylogeny / SARS-CoV-2 / COVID-19 Limits: Humans Country/Region as subject: Europa Language: En Journal: Microbiol Spectr Year: 2021 Document type: Article Affiliation country: España Country of publication: Estados Unidos